{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T12:59:36Z","timestamp":1774529976739,"version":"3.50.1"},"reference-count":50,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archives de P\u00e9diatrie"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1016\/j.arcped.2017.09.002","type":"journal-article","created":{"date-parts":[[2017,11,13]],"date-time":"2017-11-13T15:01:43Z","timestamp":1510585303000},"page":"1312-1320","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Traitements du syndrome n\u00e9phrotique cortico-d\u00e9pendant de l\u2019enfant"],"prefix":"10.1016","volume":"24","author":[{"given":"A.","family":"Couderc","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"B\u00e9rard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2529-0919","authenticated-orcid":false,"given":"V.","family":"Guigonis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Vrillon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Hogan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"Audard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"Baudouin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Dossier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O.","family":"Boyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.arcped.2017.09.002_bib0005","series-title":"Protocole national de diagnostic et de soins pour une maladie rare. Syndrome n\u00e9phrotique idiopathique de l\u2019enfant","author":"Haute Autorit\u00e9 de sant\u00e9","year":"2016"},{"key":"10.1016\/j.arcped.2017.09.002_bib0010","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0140-6736(03)14184-0","article-title":"Nephrotic syndrome in childhood","volume":"362","author":"Eddy","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.arcped.2017.09.002_bib0015","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/S0022-3476(81)80760-3","article-title":"The primary nephrotic syndrome in children. Identification of patients with minimal change nephrotic syndrome from initial response to prednisone. A report of the International Study of Kidney Disease in Children","volume":"98","author":"ISKDC","year":"1981","journal-title":"J Pediatr"},{"key":"10.1016\/j.arcped.2017.09.002_bib0020","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s00467-012-2310-x","article-title":"Treatment of steroid-sensitive nephrotic syndrome: new guidelines from KDIGO","volume":"28","author":"Lombel","year":"2013","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.arcped.2017.09.002_bib0025","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1542\/peds.2008-1559","article-title":"Management of childhood onset nephrotic syndrome","volume":"124","author":"Gipson","year":"2009","journal-title":"Pediatrics"},{"key":"10.1016\/j.arcped.2017.09.002_bib0030","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.nephro.2005.06.003","article-title":"Syndrome n\u00e9phrotique pur (ou n\u00e9phrose) corticosensible de l\u2019enfant\u00a0: protocole de traitement propos\u00e9 par la Soci\u00e9t\u00e9 de n\u00e9phrologie p\u00e9diatrique","volume":"1","author":"B\u00e9rard","year":"2005","journal-title":"Nephrol Ther"},{"key":"10.1016\/j.arcped.2017.09.002_bib0035","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/BF00442096","article-title":"[No authors listed]. Alternate-day prednisone is more effective than intermittent prednisone in frequently relapsing nephrotic syndrome. A report of Arbeitsgemeinschaft f\u00fcr P\u00e4diatrische Nephrologie","volume":"135","year":"1981","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.arcped.2017.09.002_bib0040","first-page":"380","article-title":"[No authors listed]. Short versus standard prednisone therapy for initial treatment of idiopathic nephrotic syndrome in children. Arbeitsgemeinschaft f\u00fcr P\u00e4diatrische Nephrologie","volume":"1","year":"1988","journal-title":"Lancet"},{"key":"10.1016\/j.arcped.2017.09.002_bib0045","first-page":"CD002290","article-title":"Non-corticosteroid immunosuppressive medications for steroid-sensitive nephrotic syndrome in children","volume":"10","author":"Pravitsitthikul","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.arcped.2017.09.002_bib0050","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1007\/s00467-005-1968-8","article-title":"Evidence-based management of steroid-sensitive nephrotic syndrome","volume":"20","author":"Hodson","year":"2005","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.arcped.2017.09.002_bib0055","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1681\/ASN.2012070646","article-title":"Extending prednisolone treatment does not reduce relapses in childhood nephrotic syndrome","volume":"24","author":"Teeninga","year":"2013","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.arcped.2017.09.002_bib0060","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/ki.2014.260","article-title":"A multicenter randomized trial indicates initial prednisolone treatment for childhood nephrotic syndrome for two months is not inferior to six-month treatment","volume":"87","author":"Yoshikawa","year":"2015","journal-title":"Kidney Int"},{"key":"10.1016\/j.arcped.2017.09.002_bib0065","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1007\/s00467-015-3106-6","article-title":"Corticosteroids for the initial episode of steroid-sensitive nephrotic syndrome","volume":"30","author":"Hodson","year":"2015","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.arcped.2017.09.002_bib0070","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/0192-0561(91)90019-4","article-title":"On the biochemical mode of action of levamisole: an update","volume":"13","author":"Van Wauwe","year":"1991","journal-title":"Inter J Immunopharmacol"},{"key":"10.1016\/j.arcped.2017.09.002_bib0075","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/S0022-3476(80)80707-4","article-title":"Treatment of nephrotic syndrome with levamisole","volume":"96","author":"Tanphaichitr","year":"1980","journal-title":"J Pediatr"},{"key":"10.1016\/j.arcped.2017.09.002_bib0080","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.2460\/javma.1980.176.10.1159","article-title":"Immunomodulatory effects of levamisole","volume":"176","author":"Brunner","year":"1980","journal-title":"J Am Vet Med Assoc"},{"key":"10.1016\/j.arcped.2017.09.002_bib0085","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1046\/j.1365-2567.2000.00042.x","article-title":"Levamisole induces interleukin-18\u00a0and shifts type 1\/type 2\u00a0cytokine balance","volume":"100","author":"Szeto","year":"2000","journal-title":"Immunology"},{"key":"10.1016\/j.arcped.2017.09.002_bib0090","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1111\/j.1365-2249.2007.03541.x","article-title":"Levamisole enhances immune response by affecting the activation and maturation of human monocyte-derived dendritic cells","volume":"151","author":"Chen","year":"2008","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.arcped.2017.09.002_bib0095","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1111\/bcp.12607","article-title":"Population pharmacokinetics of levamisole in children with steroid-sensitive nephrotic syndrome","volume":"80","author":"Kreeftmeijer-Vegter","year":"2015","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.arcped.2017.09.002_bib0100","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1007\/s00467-007-0708-7","article-title":"Short- and long-term efficacy of levamisole as adjunctive therapy in childhood nephrotic syndrome","volume":"23","author":"Boyer","year":"2008","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.arcped.2017.09.002_bib0105","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1007\/s00467-004-1608-8","article-title":"Long-term effects of levamisole treatment in childhood nephrotic syndrome","volume":"19","author":"S\u00fcmegi","year":"2004","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.arcped.2017.09.002_bib0110","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/BF00865500","article-title":"Side effects of levamisole in children with nephrosis","volume":"8","author":"Palcoux","year":"1994","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.arcped.2017.09.002_bib0115","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1007\/s004670050753","article-title":"Disseminated autoimmune disease during levamisole treatment of nephrotic syndrome","volume":"13","author":"Barbano","year":"1999","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.arcped.2017.09.002_bib0120","doi-asserted-by":"crossref","first-page":"S181","DOI":"10.1097\/01.tp.0000186390.10150.66","article-title":"Mechanisms of action of mycophenolate mofetil in preventing acute and chronic allograft rejection","volume":"80","author":"Allison","year":"2005","journal-title":"Transplantation"},{"key":"10.1016\/j.arcped.2017.09.002_bib0125","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1053\/j.ajkd.2003.08.011","article-title":"Mycophenolate mofetil and prednisolone therapy in children with steroid-dependent nephrotic syndrome","volume":"42","author":"Bagga","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.arcped.2017.09.002_bib0130","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s00467-003-1300-4","article-title":"Frequently relapsing nephrotic syndrome: treatment with mycophenolate mofetil","volume":"19","author":"Gellermann","year":"2004","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.arcped.2017.09.002_bib0135","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s00467-011-2006-7","article-title":"Mycophenolate mofetil for steroid-dependent nephrotic syndrome: a phase II Bayesian trial","volume":"27","author":"Baudouin","year":"2012","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.arcped.2017.09.002_bib0140","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.2215\/CJN.00550206","article-title":"Mycophenolate mofetil in children with frequently relapsing nephrotic syndrome: a report from the Southwest Pediatric Nephrology Study Group","volume":"1","author":"Hogg","year":"2006","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.arcped.2017.09.002_bib0145","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s00467-006-0294-0","article-title":"A prospective study on the use of mycophenolate mofetil in children with cyclosporine-dependent nephrotic syndrome","volume":"22","author":"Fujinaga","year":"2007","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.arcped.2017.09.002_bib0150","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1007\/s00467-004-1778-4","article-title":"Switch from cyclosporine A to mycophenolate mofetil in nephrotic children","volume":"20","author":"Ulinski","year":"2005","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.arcped.2017.09.002_bib0155","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1007\/s00467-005-1877-x","article-title":"Mycophenolate mofetil in steroid\/cyclosporine-dependent\/resistant nephrotic syndrome","volume":"20","author":"Mendiz\u00e1bal","year":"2005","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.arcped.2017.09.002_bib0160","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1681\/ASN.2012121200","article-title":"Mycophenolate mofetil versus cyclosporin A in children with frequently relapsing nephrotic syndrome","volume":"24","author":"Gellermann","year":"2013","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.arcped.2017.09.002_bib0165","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1007\/s00467-008-0899-6","article-title":"Mycophenolate mofetil versus cyclosporine for remission maintenance in nephrotic syndrome","volume":"23","author":"Dorresteijn","year":"2008","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.arcped.2017.09.002_bib0170","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1007\/s00467-007-0617-9","article-title":"Treatment with mycophenolate mofetil and prednisolone for steroid-dependent nephrotic syndrome","volume":"22","author":"Afzal","year":"2007","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.arcped.2017.09.002_bib0175","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1007\/s00467-016-3400-y","article-title":"Mycophenolate mofetil in steroid-dependent idiopathic nephrotic syndrome","volume":"31","author":"Dehoux","year":"2016","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.arcped.2017.09.002_bib0180","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.2215\/CJN.00320116","article-title":"Mycophenolic acid pharmacokinetics and relapse in children with steroid-dependent idiopathic nephrotic syndrome","volume":"11","author":"Tellier","year":"2016","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.arcped.2017.09.002_bib0185","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1007\/s00467-011-1830-0","article-title":"Cyclophosphamide in steroid-dependent nephrotic syndrome","volume":"26","author":"Azib","year":"2011","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.arcped.2017.09.002_bib0190","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1136\/archdischild-2015-308924","article-title":"Steroid-sensitive nephrotic syndrome: an evidence-based update of immunosuppressive treatment in children","volume":"101","author":"Larkins","year":"2016","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.arcped.2017.09.002_bib0195","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s004670000523","article-title":"A meta-analysis of cytotoxic treatment for frequently relapsing nephrotic syndrome in children","volume":"16","author":"Latta","year":"2001","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.arcped.2017.09.002_bib0200","first-page":"CD002290","article-title":"Non-corticosteroid treatment for nephrotic syndrome in children","author":"Hodson","year":"2008","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.arcped.2017.09.002_bib0205","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1007\/s00467-012-2228-3","article-title":"Treatment of tacrolimus or cyclosporine A in children with idiopathic nephrotic syndrome","volume":"27","author":"Wang","year":"2012","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.arcped.2017.09.002_bib0210","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/nep.12537","article-title":"Evaluation of mycophenolate mofetil or tacrolimus in children with steroid sensitive but frequently relapsing or steroid-dependent nephrotic syndrome","volume":"21","author":"Wang","year":"2016","journal-title":"Nephrology (Carlton)"},{"key":"10.1016\/j.arcped.2017.09.002_bib0215","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.2215\/CJN.01520209","article-title":"Risk factors for cyclosporin A nephrotoxicity in children with steroid-dependant nephrotic syndrome","volume":"4","author":"Kengne-Wafo","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.arcped.2017.09.002_bib0220","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1007\/s00467-004-1434-z","article-title":"Change of the course of steroid-dependent nephrotic syndrome after rituximab therapy","volume":"19","author":"Benz","year":"2004","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.arcped.2017.09.002_bib0225","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1007\/s00467-008-0814-1","article-title":"Rituximab treatment for severe steroid- or cyclosporine-dependent nephrotic syndrome: a multicentric series of 22\u00a0cases","volume":"23","author":"Guigonis","year":"2008","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.arcped.2017.09.002_bib0230","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1681\/ASN.2013030251","article-title":"Rituximab in steroid-dependent or frequently relapsing idiopathic nephrotic syndrome","volume":"25","author":"Ruggenenti","year":"2014","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.arcped.2017.09.002_bib0235","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1016\/S0140-6736(14)60541-9","article-title":"Rituximab for childhood-onset, complicated, frequently relapsing nephrotic syndrome or steroid-dependent nephrotic syndrome: a multicentre, double-blind, randomised, placebo-controlled trial","volume":"384","author":"Iijima","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.arcped.2017.09.002_bib0240","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1093\/ndt\/gfr405","article-title":"Rituximab in steroid-dependent idiopathic nephrotic syndrome in childhood\u00a0\u2014\u00a0follow-up after CD19\u00a0recovery","volume":"27","author":"Sellier-Leclerc","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.arcped.2017.09.002_bib0245","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1007\/s00467-013-2485-9","article-title":"Fulminant viral myocarditis after rituximab therapy in pediatric nephrotic syndrome","volume":"28","author":"Sellier-Leclerc","year":"2013","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.arcped.2017.09.002_bib0250","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1056\/NEJMc1308488","article-title":"Ofatumumab for rituximab-resistant nephrotic syndrome","volume":"370","author":"Basu","year":"2014","journal-title":"N Engl J Med"}],"container-title":["Archives de P\u00e9diatrie"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0929693X17303871?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0929693X17303871?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,27]],"date-time":"2025-06-27T00:23:36Z","timestamp":1750983816000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0929693X17303871"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":50,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["S0929693X17303871"],"URL":"https:\/\/doi.org\/10.1016\/j.arcped.2017.09.002","relation":{},"ISSN":["0929-693X"],"issn-type":[{"value":"0929-693X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Traitements du syndrome n\u00e9phrotique cortico-d\u00e9pendant de l\u2019enfant","name":"articletitle","label":"Article Title"},{"value":"Archives de P\u00e9diatrie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.arcped.2017.09.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}